Journal of Asthma and Allergy
Volume 11, 2018 - Issue
Open access
105
Views
22
CrossRef citations to date
0
Altmetric
Original Research
Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial
Pamela L Zeitlin1 Department of Pediatrics, National Jewish Health, Denver, CO, USA, [email protected]Correspondence[email protected]
, Mila Leong2 Pediatric Pulmonary and Asthma Associates, Northfield, NJ, USA
, Jeremy Cole3 OK Clinical Research, LLC, Edmond, OK, USA
, Raburn M Mallory4 MedImmune LLC, Gaithersburg, MD, USA
, Vivian H Shih5 AstraZeneca, Gaithersburg, MD, USA
, Richard F Olsson6 AstraZeneca, Gothenburg, Sweden
, Mitchell Goldman5 AstraZeneca, Gaithersburg, MD, USA
& On behalf of the ALIZE study investigators show all
Pages 181-192
|
Published online: 16 Aug 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.